 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Imugene Ltd. is a biopharmaceutical company, which engages in the research, development, and commercialisation of health technologies against cancer. Its products include b-cell peptide cancer vaccines, arginine modulators, and mimotopes. The company was founded on May 30, 1986 and is headquartered in Sydney, Australia.

Current Price	$0.0702
Prev Close	$0.0733
Open	$0.0728
Dividend Yield	0.00%
50-Day Moving Average	$0.0863
Beta	1.05
Avg. Volume	70,684.68
PE Ratio	-14.63

52-Week High	$0.2126
52-Week Low	$0.0631
Market Capitalization	$450.9M
EPS	-$0.0048
Price to Book	3.21
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

IUGNF Imugene Limited

About

Feed

Fundamentals

News